Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice

Experimental Parasitology

Volumn 125, Issue 3, 2010, Pages 271-278

  Lacerda Queiroz, Norinne ^a   Rodrigues, David Henrique ^a   Vilela, Márcia Carvalho ^a   Miranda, Aline Silva de ^a   Amaral, Débora Cristina Guerra ^a   Camargos, Elizabeth Ribeiro da Silva ^a   Carvalho, Leonardo José de Moura ^b,c   Howe, Charles L ^d   Teixeira, Mauro Martins ^a   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

Behavior; Cerebral malaria; Cytokines; Intravital microscopy; Leukocyte recruitment

Indexed keywords

CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL BETA GLUCOSAMINIDASE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR CHANGE; BRAIN MALARIA; BRAIN MICROCIRCULATION; C57BL 6 MOUSE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; HISTOPATHOLOGY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LOCOMOTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONOCYTE; MOUSE; MUSCLE REFLEX; MUSCLE STRENGTH; MUSCLE TONE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SENSORY SYSTEM;

ACETYLGLUCOSAMINIDASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHEMOKINES; MACROPHAGES; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MONOCYTES; PIA MATER; PLASMODIUM BERGHEI;

MUS; PLASMODIUM BERGHEI STRAIN ANKA;

EID: 77952581022     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.02.002     Document Type: Article

References (34)

1. Bagot S., Idrissa Boubou M., Campino S., Behrschmidt C., Gorgette O., Guenet J.L., Penha-Goncalves C., Mazier D., Pied S., Cazenave P.A. Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock. Infection and Immunity 2002, 70:2049-2056.
2. Barcelos L.S., Talvani A., Teixeira A.S., Vieira L.Q., Cassali G.D., Andrade S.P., Teixeira M.M. Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1. Journal of Leukocyte Biology 2005, 78:352-358.
3. + T cells in experimental cerebral malaria. Journal of Immunology 2002, 169:6369-6375.
4. Campanella G.S., Tager A.M., El Khoury J.K., Thomas S.Y., Abrazinski T.A., Manice L.A., Colvin R.A., Luster A.D. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4814-4819.
5. Cutrullis R.A., Postan M., Petray P.B., Corral R.S. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Pathobiology 2009, 76:170-180.
6. Desruisseaux M.S., Gulinello M., Smith D.N., Lee S.C., Tsuji M., Weiss L.M., Spray D.C., Tanowitz H.B. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. The Journal of Infectious Diseases 2008, 197:1621-1627.
7. de Souza J.B., Riley E.M. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes and Infection 2002, 4:291-300.
8. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. Journal of Leukocyte Biology 1997, 61:246-257.
9. Grau G.E., Piguet P.F., Engers H.D., Louis J.Á., Vassali P., Lambert P.H. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. Journal of Immunology 1986, 137:2348-2354.
10. Grau G.E., Fajardo L.F., Piguet P.F., Allet B., Lambert P.H., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987, 237:1210-1212.
11. Idro R., Carter J.A., Fegan G., Neville B.G., Newton C.R. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Archives of Disease in Childhood 2006, 91:142-148.
12. Hanum P.S., Hayano M., Kojima S. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. International Immunology 2003, 15:633-640.
13. John C.C., Bangirana P., Byarugaba J., Opoka R.O., Idro R., Jurek A.M., Wu B., Boivin M.J. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 2008, 122:92-99.
14. John C.C., Panoskaltsis-Mortari A., Opoka R.O., Park G.S., Orchard P.J., Jurek A.M., Idro R., Byarugaba J., Boivin M.J. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. The American Journal of Tropical Medicine and Hygiene 2008, 78:198-205.
15. Lackner P., Beer R., Helbok R., Broessner G., Engelhardt K., Brenneis C., Schmutzhard E., Pfaller K. Scanning electron microscopy of the neuropathology of murine cerebral malaria. Malaria Journal 2006, 5:116.
16. Lackner P., Beer R., Heussler V., Goebel G., Rudzki D., Helbok R., Tannich E., Schmutzhard E. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathology and Applied Neurobiology 2006, 32:177-188.
17. Lalonde R., Dumont M., Staufenbiel M., Strazielle C. Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behavioural Brain Research 2005, 157:91-98.
18. Lou J., Lucas R., Grau G.E. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clinical Microbiology Reviews 2001, 14:810-820.
19. Martins Y.C., Smith M.J., Pelajo-Machado M., Werneck G.L., Lenzi H.L., Daniel-Ribeiro C.T., Carvalho L.J. Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. International Journal of Experimental Pathology 2009, 90:119-130.
20. Medana I.M., Chaudhri G., Chan-Ling T., Hunt N.H. Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? Immunology and Cell Biology 2001, 79:101-120.
21. Medana I.M., Turner G.D. Human cerebral malaria and the blood-brain barrier. International Journal for Parasitology 2006, 36:555-568.
22. Menke J., Zeller G.C., Kikawada E., Means T.K., Huang X.R., Lan H.Y., Lu B., Farber J., Luster A.D., Kelley V.R. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. Journal of the American Society of Nephrology: JASN 2008, 19:1177-1189.
23. Miu J., Mitchell A.J., Müller M., Carter S.L., Manders P.M., McQuillan J.A., Saunders B.M., Ball H.J., Lu B., Campbell I.L., Hunt N.H. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. Journal of Immunology 2008, 180:1217-1230.
24. Nie C.Q., Bernard N.J., Norman M.U., Amante F.H., Lundie R.J., Crabb B.S., Heath W.R., Engwerda C.R., Hickey M.J., Schofield L., Hansen D.S. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathogens 2009, 5:e1000369.
25. Ransohoff R.M. The chemokine system in neuroinflammation: an update. The Journal of Infectious Diseases 2002, 186:152-156.
26. Reiner R.G., Tanner A.R., Keyhani A.H., Wright R. A comparative study of lysosomal enzyme activity in monocytes and Kupffer cells isolated simultaneously in a rat model of liver injury. Clinical and Experimental Immunology 1981, 43:376-380.
27. Rogers D.C., Fisher E.M., Brown S.D., Peters J., Hunter A.J., Martin J.E. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mammalian Genome 1997, 8:711-713.
28. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathology and Applied Neurobiology 2000, 26:133-142.
29. Sui Z., Sniderhan L.F., Schifitto G., Phipps R.P., Gelbard H.A., Dewhurst S., Maggirwar S.B. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. Journal of Immunology 2007, 178:3226-3236.
30. Van den Steen P.E., Deroost K., Van Aelst I., Geurts N., Martens E., Struyf S., Nie C.Q., Hansen D.S., Matthys P., Van Damme J., Opdenakker G. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. European Journal of Immunology 2008, 38:1082-1095.
31. van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends in Parasitology 2006, 22:503-508.
32. Vilela M.C., Mansur D.S., Lacerda-Queiroz N., Rodrigues D.H., Arantes R.M., Kroon E.G., Campos M.A., Teixeira M.M., Teixeira A.L. Traffic of leukocytes in the central nervous system is associated with chemokine up-regulation in a severe model of herpes simplex encephalitis: an intravital microscopy study. Neuroscience Letters 2008, 445:18-22.
33. Vilela M.C., Mansur D.S., Lacerda-Queiroz N., Rodrigues D.H., Lima G.K., Arantes R.M., Kroon E.G., da Silva Campos M.A., Teixeira M.M., Teixeira A.L. The chemokine CCL5 is essential for leukocyte recruitment in a model of severe herpes simplex encephalitis. Annals of the New York Academy of Sciences 2009, 1153:256-263.
34. Severe falciparum malaria: World Health Organization, communicable diseases cluster. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000, 94:S1-S90. WHO.